Kyleena (Levonorgestrel)

Levonorgestrel released from the IUS thickens cervical mucus, reduces sperm motility, suppresses the growth of the uterine lining, and may inhibit ovulation. These mechanisms together create an environment that prevents fertilisation and implantation, delivering reliable contraception.

The dosage of Kyleena is determined by the prescriber based on the approved 19.5 mg levonorgestrel intrauterine system. The device is inserted by a qualified healthcare professional and remains effective for up to five years without the need for daily dosing.

Kyleena must not be used by women who are pregnant; it is intended for contraception before pregnancy occurs. If pregnancy is confirmed, the device should be removed. Limited data are available for breastfeeding, and clinicians should weigh benefits against potential risks before insertion.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Kyleena contains 19.5 mg levonorgestrel, offering a slightly lower hormone dose than some alternatives while still providing up to five years of protection. Compared with copper IUDs, it may cause less menstrual bleeding but does not protect against sexually transmitted infections.

Kyleena should be stored at room temperature, below 25 °C, in its original sealed packaging. Protect the device from moisture, direct sunlight and extreme temperatures to maintain its integrity until insertion by a qualified professional.

Kyleena is a sterile intrauterine system that is inserted through the cervix into the uterine cavity by a trained healthcare provider. The procedure is performed in a clinical setting using aseptic technique, and the device remains in place for up to five years.

Serious risks, though uncommon, include uterine perforation during insertion, expulsion of the device, pelvic inflammatory infection, and ectopic pregnancy if contraception fails. Patients should seek immediate medical attention for severe abdominal pain, abnormal bleeding or signs of infection.

Kyleena is contraindicated in women who are pregnant, have active pelvic infection, unexplained vaginal bleeding, uterine anomalies, or a known hypersensitivity to levonorgestrel. It should also be avoided in patients with a history of uterine perforation or certain cancers of the reproductive tract.